Supplementary Data 1 from INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Jérôme Fayette(Université Claude Bernard Lyon 1), Jan Paul de Boer, Paul M. Clément(Universitair Ziekenhuis Leuven), Lúcia Águas, Tanguy Y. Seiwert(Georgetown University), Makoto Tahara(National Cancer Center Hospital East), Robert L. Metcalf(The Christie NHS Foundation Trust), Jessica R. Bauman, Paolo Bossi(Humanitas University), Tsung-Ming Chen, Anirudha Dasgupta, Maureen Bernadach, Myung‐Ju Ahn(Sungkyunkwan University), Helena Rebelo‐de‐Andrade(University of Lisbon), Lisa Licitra(University of Milan), Santiago Cabezas Camarero, Ann Hoeben(Maastricht University Medical Centre), Amanda Psyrri(National and Kapodistrian University of Athens), Douglas R. Adkins(Washington University in St. Louis), Jorge Blando(AstraZeneca (Netherlands)), Ulrich Keilholz(German Cancer Research Center), Jean‐Pascal Machiels(Cliniques Universitaires Saint-Luc), José Dinis(Instituto Português de Oncologia Francisco Gentil), Michael S. Hwang(Howard Hughes Medical Institute), Vyacheslav Chubenko, Federica Bertolini, Kevin J. Harrington(Royal Marsden NHS Foundation Trust), А. М. Мудунов(Italian Society of Periodontology and Implantology), Michael Boyer(Chris O’Brien Lifehouse), Dario Ruscica(AstraZeneca (United Kingdom)), Bhumsuk Keam(Seoul National University Hospital), Robert I. Haddad(Georgetown University), Amaury Daste(Centre Hospitalier Universitaire de Bordeaux), Robert L. Ferris(University of Pittsburgh), Yi‐Chun Liu(Stomatology Hospital), P. A. Isaev(Medical Radiological Research Center), Christian Borel, Ching-Yun Hsieh(China Medical University), Wonyoung Choi, Lillian L. Siu(University Health Network), Olivier Serrano(AstraZeneca (France)), Marcelo Bonomi
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k